Literature DB >> 20149408

Levels of perfluorooctane sulfonate and perfluorooctanoic acid in female serum samples from Japan in 2008, Korea in 1994-2008 and Vietnam in 2007-2008.

Kouji H Harada1, Hye-Ran Yang, Chan-Seok Moon, Nguyen Ngoc Hung, Toshiaki Hitomi, Kayoko Inoue, Tamon Niisoe, Takao Watanabe, Shigetoshi Kamiyama, Katsunobu Takenaka, Min-Young Kim, Kiyohiko Watanabe, Takumi Takasuga, Akio Koizumi.   

Abstract

Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) have recently received attention owing to their widespread contamination in the environment. One of major manufacturers, 3M Company voluntarily phased out PFOS production in 2002. We measured the PFOS and PFOA concentrations in serum samples from Japan (Sendai, Takayama and Osaka), Korea (Busan and Seoul) and Vietnam (Hanoi) to evaluate the possible effects of the phase-out on the serum levels. There were spatial differences in both the serum PFOS and PFOA concentrations. The serum PFOS concentrations (ngmL(-1)) evaluated as the geometric mean (geometric standard deviation) in 2007-2008 ranged from 4.86 (1.45) in Sendai, Japan, to 9.36 (1.42) in Busan, Korea. The serum PFOA concentrations ranged from 0.575 (2.32) in Hanoi, Vietnam, to 14.2 (1.73) in Osaka, Japan. Historically archived samples collected from Korea in 1994-2008 revealed that the serum PFOA concentrations increased by 1.24-fold in Busan from 2000 to 2008 and 1.41-fold in Seoul from 1994 to 2007. On the other hand, the serum PFOS concentrations did not change from 1994 to 2007/2008. The serum PFOS levels in Japan in 2008 were significantly decreased compared with previously reported values (22.3-66.7% of the values in 2003/2004). However, the serum PFOA levels showed a clear decline from 2003 to 2008 in a high-exposed area, Osaka, but not in low-exposed areas in Japan. The trends toward decreases were not uniformly observed in Asian countries, unlike the case for the United States, suggesting that local factors associated with the production and introduction histories in each country overwhelm the effects of the phase-out. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149408     DOI: 10.1016/j.chemosphere.2010.01.027

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  14 in total

1.  Contamination by perfluorinated compounds in water near waste recycling and disposal sites in Vietnam.

Authors:  Joon-Woo Kim; Nguyen Minh Tue; Tomohiko Isobe; Kentaro Misaki; Shin Takahashi; Pham Hung Viet; Shinsuke Tanabe
Journal:  Environ Monit Assess       Date:  2012-07-07       Impact factor: 2.513

2.  Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

Authors:  L-M L Toms; J Thompson; A Rotander; P Hobson; A M Calafat; K Kato; X Ye; S Broomhall; F Harden; J F Mueller
Journal:  Environ Int       Date:  2014-06-27       Impact factor: 9.621

3.  Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.

Authors:  Kim E Innes; Alan M Ducatman; Michael I Luster; Anoop Shankar
Journal:  Am J Epidemiol       Date:  2011-06-27       Impact factor: 4.897

4.  Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

Authors:  Claire Looker; Michael I Luster; Antonia M Calafat; Victor J Johnson; Gary R Burleson; Florence G Burleson; Tony Fletcher
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

5.  Association of perfluorinated chemical exposure in utero with maternal and infant thyroid hormone levels in the Sapporo cohort of Hokkaido Study on the Environment and Children's Health.

Authors:  Shizue Kato; Sachiko Itoh; Motoyuki Yuasa; Toshiaki Baba; Chihiro Miyashita; Seiko Sasaki; Sonomi Nakajima; Akiko Uno; Hiroyuki Nakazawa; Yusuke Iwasaki; Emiko Okada; Reiko Kishi
Journal:  Environ Health Prev Med       Date:  2016-04-30       Impact factor: 3.674

6.  Estrogen receptor beta mediates hepatotoxicity induced by perfluorooctane sulfonate in mouse.

Authors:  Cheng Xu; Zhao-Yan Jiang; Qian Liu; Hui Liu; Aihua Gu
Journal:  Environ Sci Pollut Res Int       Date:  2017-04-07       Impact factor: 4.223

7.  Insights into perfluorooctane sulfonate photodegradation in a catalyst-free aqueous solution.

Authors:  Xian-Jin Lyu; Wen-Wei Li; Paul K S Lam; Han-Qing Yu
Journal:  Sci Rep       Date:  2015-03-23       Impact factor: 4.379

8.  Chronic exposure to perfluorooctane sulfonate induces behavior defects and neurotoxicity through oxidative damages, in vivo and in vitro.

Authors:  Na Chen; Jia Li; Dan Li; Yongsheng Yang; Defu He
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

9.  Prenatal Exposure to Perfluorocarboxylic Acids (PFCAs) and Fetal and Postnatal Growth in the Taiwan Maternal and Infant Cohort Study.

Authors:  Yan Wang; Margaret Adgent; Pen-Hua Su; Hsiao-Yen Chen; Pau-Chung Chen; Chao A Hsiung; Shu-Li Wang
Journal:  Environ Health Perspect       Date:  2016-02-19       Impact factor: 9.031

10.  Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis.

Authors:  Jeffrey Wimsatt; Meghan Villers; Laurel Thomas; Stacey Kamarec; Caitlin Montgomery; Leo W Y Yeung; Yanqing Hu; Kim Innes
Journal:  BMC Cancer       Date:  2016-12-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.